Timing and why we’re all VCs
TechCrunch LA
FEBRUARY 20, 2019
From the article: Mithril had its best moment yet last week when a portfolio company, Auris Health, sold to Johnson & Johnson for more than $3 billion — returning at least $500 million to the fund. You allow us to get off the ad-laden media churn conveyor belt and spend quality time on amazing ideas, people, and companies.
202 
Let's personalize your content